Total Payments
$33,862
2024 Payments
$3,749
Companies
59
Transactions
1,387
Medicare Patients
9,280
Medicare Billing
$944,142
Payment Breakdown by Category
Food & Beverage$23,862 (70.5%)
Education$9,000 (26.6%)
Travel$999.98 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,862 | 1,380 | 70.5% |
| Education | $9,000 | 3 | 26.6% |
| Travel and Lodging | $999.98 | 4 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $10,937 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $4,248 | 371 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,855 | 198 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,794 | 104 | $0 (2024) |
| GENZYME CORPORATION | $1,401 | 41 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,189 | 47 | $0 (2024) |
| Grifols USA, LLC | $1,012 | 58 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $835.28 | 46 | $0 (2024) |
| Mylan Specialty L.P. | $810.92 | 52 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $795.17 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,749 | 182 | AstraZeneca Pharmaceuticals LP ($783.71) |
| 2023 | $14,094 | 204 | Intuitive Surgical, Inc. ($10,649) |
| 2022 | $3,447 | 188 | AstraZeneca Pharmaceuticals LP ($765.73) |
| 2021 | $2,874 | 180 | GlaxoSmithKline, LLC. ($474.72) |
| 2020 | $2,202 | 152 | GlaxoSmithKline, LLC. ($736.43) |
| 2019 | $2,482 | 155 | GlaxoSmithKline, LLC. ($588.16) |
| 2018 | $2,868 | 174 | GlaxoSmithKline, LLC. ($649.83) |
| 2017 | $2,147 | 152 | GlaxoSmithKline, LLC. ($375.82) |
All Payment Transactions
1,387 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $0.48 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $21.90 | General |
| Category: Medical Device | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $37.49 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Oncology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,151 | 3,244 | $568,847 | $217,322 |
| 2022 | 19 | 2,260 | 3,499 | $617,183 | $229,919 |
| 2021 | 19 | 2,416 | 3,693 | $645,700 | $251,457 |
| 2020 | 20 | 2,453 | 3,723 | $658,237 | $245,445 |
Total Patients
9,280
Total Services
14,159
Medicare Billing
$944,142
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 336 | 493 | $107,035 | $47,224 | 44.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 324 | 747 | $107,568 | $45,741 | 42.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 126 | 384 | $79,488 | $35,462 | 44.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 176 | 188 | $75,200 | $25,216 | 33.5% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 324 | 477 | $50,085 | $13,502 | 27.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 194 | 215 | $22,790 | $8,902 | 39.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 181 | 198 | $21,186 | $7,952 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 49 | $14,210 | $6,561 | 46.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $13,821 | $6,548 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 56 | $8,176 | $3,771 | 46.1% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 28 | 29 | $15,515 | $2,849 | 18.4% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 14 | 15 | $7,905 | $2,362 | 29.9% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 190 | 211 | $11,183 | $2,341 | 20.9% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 12 | 12 | $6,972 | $2,245 | 32.2% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 28 | 30 | $5,940 | $2,205 | 37.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,400 | $1,872 | 42.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 43 | 46 | $4,554 | $1,172 | 25.7% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 15 | 15 | $10,830 | $838.92 | 7.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 17 | 17 | $1,989 | $557.08 | 28.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 444 | 1,029 | $148,176 | $56,969 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 304 | 446 | $96,836 | $42,874 | 44.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 228 | 252 | $100,800 | $38,890 | 38.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 137 | 347 | $71,829 | $27,829 | 38.7% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 306 | 450 | $47,250 | $12,857 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 82 | $23,780 | $11,233 | 47.2% |
About Dr. Scott Zuick, MD
Dr. Scott Zuick, MD is a Pulmonary Disease healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609800176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Zuick, MD has received a total of $33,862 in payments from pharmaceutical and medical device companies, with $3,749 received in 2024. These payments were reported across 1,387 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($23,862).
As a Medicare-enrolled provider, Zuick has provided services to 9,280 Medicare beneficiaries, totaling 14,159 services with total Medicare billing of $944,142. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Saint Louis, MO
- Active Since 07/10/2006
- Last Updated 01/17/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609800176
Products in Payments
- Da Vinci Surgical System (Device) $7,937
- ION (Device) $3,000
- DUPIXENT (Biological) $2,391
- TRELEGY ELLIPTA (Drug) $1,847
- BREZTRI (Drug) $1,169
- NUCALA (Biological) $1,092
- OFEV (Drug) $885.25
- TEZSPIRE (Biological) $811.25
- Prolastin-C Liquid (Biological) $795.16
- XOLAIR (Biological) $603.37
- STIOLTO RESPIMAT (Drug) $550.22
- FASENRA (Drug) $540.47
- SMARTVEST (Device) $523.90
- SYMBICORT (Drug) $503.98
- GLASSIA (Biological) $502.85
- OPSUMIT (Drug) $451.41
- FASENRA (Biological) $447.26
- Yupelri (Drug) $419.76
- ORENITRAM (Drug) $404.81
- ANORO (Drug) $400.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Saint Louis
Joseph Ojile, M.d, M.D
Pulmonary Disease — Payments: $978,724
Pulmonary Disease $978,724
Dr. Alexander Chen, Md, MD
Pulmonary Disease — Payments: $859,735
Pulmonary Disease $859,735
Dr. Derek Byers, Md, MD
Pulmonary Disease — Payments: $835,202
Pulmonary Disease $835,202
Dr. Marin Kollef, Md, MD
Pulmonary Disease — Payments: $588,781
Pulmonary Disease $588,781
Dr. Praveen Chenna, Md, MD
Pulmonary Disease — Payments: $265,830
Pulmonary Disease $265,830
Dr. Murali Chakinala, Md, MD
Pulmonary Disease — Payments: $211,522
Pulmonary Disease $211,522